Group 1 - Jiangsu Securities Regulatory Bureau has enhanced its regular visiting mechanism for listed companies, achieving a coverage rate of 64.78% by visiting 458 companies as of July 31, 2023, and resolving 446 issues to promote better development [1] - The bureau focuses on key industries, such as automotive and home appliances, to help companies leverage national policies for quality improvement and efficiency, with nearly 90% of related companies achieving profitability [2] - In the pharmaceutical sector, the bureau has guided innovative drug companies to utilize capital markets for upgrades, with one company successfully obtaining FDA approval for a new drug [2] Group 2 - The bureau supports listed companies in financing and mergers, with equity financing reaching 51.233 billion yuan from January to July 2023, and 209 new merger and acquisition disclosures, totaling over 65.084 billion yuan [3] - A total of 83 listed companies in Jiangsu have announced buyback or increase plans, amounting to 15.924 billion yuan, while 160 companies plan to conduct mid-term dividends, a 11.72% increase year-on-year [4] - The bureau has established strategic cooperation agreements with 13 cities to enhance communication and support for listed companies, leading to the stable delisting of 6 ST companies this year [5]

瑞财经 严明会近日，上海乐纯生物技术股份有限公司(以下简称：乐纯生物)披露IPO辅导进展报告（第九期），辅导机构中金公司。 乐纯生物成立于2011年，注册资本3.63亿元，业务范围覆盖一次性使用系统、过滤纯化、细胞培养、洁净室污染控制四大系列。公司董事长秦孙 星，总经理王逢。 2023-2024年，乐纯生物先后完成了对格氏流体、康晟生物、斯坦利思、飞鼎的融资并购计划。 ...